Mark R Pittelkow

6PUBLICATIONS
73CO-AUTHORS
Liquid biopsiesMedical devicesComparative language studiesToxicology (incl. clinical toxicology)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 27, 2026
TYK2 Inhibition with Deucravacitinib Improves Clinical Outcomes and Resolves Interferon-Driven Inflammation in Lichen Planopilaris.

Alyssa Stockard, Zachary Leibovit-Reiben, Bowen Hu

|Feb 14, 2025
Repurposing the composite assessment of index lesion severity scoring system in cutaneous lichen planus.

Nan Zhang, Alyssa L Stockard, Zachary Leibovit-Reiben

|Jun 14, 2022
Secukinumab for the treatment of adult-onset pityriasis rubra pilaris: a single-arm clinical trial with transcriptomic analysis.

Blake W Boudreaux, Thais P Pincelli, Puneet K Bhullar

|May 11, 2021
Recurrence of primary cutaneous CD30-positive lymphoproliferative disorder following COVID-19 vaccination.

Caitlin M Brumfiel, Meera H Patel, David J DiCaudo

|Oct 22, 2020
Toward allele-specific targeting therapy and pharmacodynamic marker for spinocerebellar ataxia type 3.

Mercedes Prudencio, Hector Garcia-Moreno, Karen R Jansen-West

Pageof 1